Characteristics and outcomes of patients with Chronic myeloid leukemia and T315I mutation following failure of imatinib mesylate therapy

Elias Jabbour, Hagop Kantarjian, Dan Jones, Megan Breeden, Guillermo Garcia-Manero, Susan O'brien, Farhad Ravandi, Gautam Borthakur, Jorge Cortes

Research output: Contribution to journalArticlepeer-review

118 Scopus citations

Fingerprint

Dive into the research topics of 'Characteristics and outcomes of patients with Chronic myeloid leukemia and T315I mutation following failure of imatinib mesylate therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds